AMRX

Amneal Pharmaceuticals, Inc.

Company with tickers: AMRX

Market Cap

$5.51B

Shares Outstanding

319,022,792

CIK

1723128

CUSIP

03168L105

13F Activity (30d)

3 filings 2 filers

Website

Visit website

Investor Relations

Investor relations

Press releases and events scraped from the company's investor relations website. News and event listings link back to the original source.

Recent news

Date	Headline
2026-06-05	Amneal Announces Full Study Population Interim Phase 4 ELEVATE-PD Results, Reinforcing Previously Reported Benefits of CREXONT® in Parkinson's Disease
2026-06-04	Amneal Announces U.S. FDA Approval of Romidepsin Injection Solution
2026-06-01	Amneal to Participate in Goldman Sachs 47th Annual Global Healthcare Conference 2026
2026-05-07	Amneal Reports First Quarter 2026 Financial Results
2026-04-22	Amneal Agrees to Acquire Kashiv BioSciences to Create Global Biosimilar Leader; Reports Strong Preliminary First Quarter 2026 Financial Results and Raises FY2026 Standalone Guidance
2026-04-20	Amneal Announces Additional Positive Interim Phase 4 ELEVATE-PD Results with CREXONT® for Parkinson’s Disease, Including Over 3 More Hours of Daily “Good On” Time When Switching from RYTARY®
2026-04-14	Amneal Launches First Two Respiratory Metered-Dose Inhalation Products in the U.S.
2026-04-09	Amneal Launches Bimatoprost Ophthalmic Solution, 0.01%
2026-04-07	Amneal to Report First Quarter 2026 Results on May 1, 2026
2026-04-07	Amneal Announces $2 Million Donation to Support Patient Access to Essential Medicines During Parkinson’s Awareness Month

Past events

Date	Event	Type
2026-06-09	Goldman Sachs 47th Annual Global Healthcare Conference 2026	Conference
2026-04-22	Amneal Investor Call	Event
2026-03-10	Barclays 28th Annual Global Healthcare Conference	Conference
2026-02-27	Amneal Pharmaceuticals Fourth Quarter 2025 Earnings Conference Call	Earnings call
2026-01-13	J.P. Morgan 2026 Healthcare Conference	Conference
2025-12-03	Piper Sandler 2025 Healthcare Conference	Conference
2025-10-30	Amneal Pharmaceuticals Third Quarter 2025 Earnings Conference Call	Earnings call
2025-08-05	Amneal Pharmaceuticals Second Quarter 2025 Earnings Conference Call	Earnings call
2025-06-10	46th Annual Goldman Sachs Global Healthcare Conference	Conference
2025-06-05	Jefferies Global Healthcare Conference	Conference
2025-05-02	Amneal Pharmaceuticals First Quarter 2025 Earnings Conference Call	Earnings call
2025-03-12	Barclays 27th Annual Global Healthcare Conference	Conference
2025-02-28	Amneal Pharmaceuticals Fourth Quarter 2024 Earnings Conference Call	Earnings call
2025-01-15	43rd Annual J.P. Morgan Healthcare Conference	Conference
2024-12-04	36th Annual Piper Sandler Healthcare Conference	Conference
2024-11-08	Amneal Pharmaceuticals Third Quarter 2024 Earnings Conference Call	Earnings call
2024-10-01	Amneal and Metsera Announce Strategic Collaboration to Develop and Supply Portfolio of Next-Generation Medicines for Obesity and Metabolic Diseases	Event
2024-08-09	Amneal Pharmaceuticals Second Quarter 2024 Earnings Conference Call	Earnings call
2024-06-05	Jefferies Global Healthcare Conference 2024	Conference
2024-05-03	Amneal Pharmaceuticals First Quarter 2024 Earnings Conference Call	Earnings call
2024-03-13	Barclays 26th Annual Global Healthcare Conference	Conference
2024-03-01	Amneal Pharmaceuticals Fourth Quarter 2023 Earnings Conference Call	Earnings call
2024-01-10	42nd Annual J.P. Morgan Healthcare Conference	Conference
2023-11-28	Piper Sandler 35th Annual Healthcare Conference	Conference
2023-11-14	2023 Jefferies London Healthcare Conference	Conference

Source: https://investors.amneal.com/investor-relations/default.aspx